Fred Hutch Cancer Center researchers are seeking better ways to prevent, detect and treat kidney cancer. We are also working to better understand the factors that affect each person’s risk for this cancer. Our scientists are also developing new methods to gauge how well a tumor will respond to treatment.
Researchers at Fred Hutch are running many clinical trials of new drugs and drug combinations to treat different types of kidney cancer. These experimental therapies are part of a trend toward precision cancer care. The idea behind precision care is to target a patient’s tumor based on its molecular profile. We continue to hunt for more potential targets on kidney cancer cells that could lead to even more treatment options.
Kidney Cancer Clinical Trials
Fred Hutch typically has over 750 active cancer clinical trials enrolling participants.
Clinical trials may allow some patients access to a promising new treatment, and help physicians and researchers learn more about a disease.
Our Kidney Cancer Researchers and Faculty
Our scientists and providers work together to prevent, diagnose and treat kidney cancer as well as other cancers and diseases. The lab research and clinical research they do are essential parts of the scientific process that leads to new treatments and better care. Many of our kidney cancer providers do research in addition to seeing patients. Clinical trials can also be a way for patients to get early access to new leading-edge therapies. Our research teams are running many clinical studies for people with kidney cancer.
See below for our researchers and faculty or view our kidney cancer care team providers.
